Allergic Rhinitis

Facial Plastic Surgery Clinics of North America

Volumn 20, Issue 1, 2012, Pages 11-20

  Mims, James W ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Allergic rhinitis; Diagnosis; Environmental control; Epidemiology; Immunotherapy

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; CETIRIZINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DECONGESTIVE AGENT; FEXOFENADINE; IMMUNOGLOBULIN E; LEUKOTRIENE; LEVOCETIRIZINE; LORATADINE; MOMETASONE FUROATE; STEROID;

ACADEMIC ACHIEVEMENT; ALLERGIC RHINITIS; BLEEDING; COUNSELING; DESENSITIZATION; DIAGNOSTIC TEST; DISEASE CONTROL; EVALUATION; FALSE POSITIVE RESULT; GENETICS; HISTORY; HUMAN; IMMUNOTHERAPY; NASAL PRURITUS; NOSE CONGESTION; OUTCOME ASSESSMENT; PATIENT SELECTION; PHYSICIAN; QUALITY OF LIFE; REVIEW; RHINORRHEA; SLEEP; SNEEZING; SUBCUTANEOUS IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY; ULCER;

ANTI-INFLAMMATORY AGENTS; ENVIRONMENT, CONTROLLED; HUMANS; IMMUNOTHERAPY; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; SKIN TESTS; UNITED STATES;

EID: 84858631140     PISSN: 10647406     EISSN: 15581926     Source Type: Journal    
DOI: 10.1016/j.fsc.2011.10.002     Document Type: Review

References (61)

1. Marple B.F., Fornadley J.A., Patel A.A., et al. Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction. Otolaryngol Head Neck Surg 2007, 136(Suppl 6):S107-S124.
2. Krouse J.H., Brown R.W., Fineman S.M., et al. Asthma and the unified airway. Otolaryngol Head Neck Surg 2007, 136(Suppl 5):S75-S106.
3. Bousquet J., Khaltaev N., Cruz A.A., et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008, 63(Suppl 86):8-160.
4. Ober C., Hoffjan S. Asthma genetics 2006: the long and winding road to gene discovery. Genes Immun 2006, 7(2):95-100.
5. Holloway J.W., Yang I.A., Holgate S.T. Genetics of allergic disease. J Allergy Clin Immunol 2010, 125(2 Suppl 2):S81-S94.
6. Smith F.J., Irvine A.D., Terron-Kwiatkowski A., et al. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet 2006, 38(3):337-342.
7. Kay A.B. Allergy and allergic diseases. Second of two parts. N Engl J Med 2001, 344(2):109-113.
8. Lieberman P. The basics of histamine biology. Ann Allergy Asthma Immunol 2011, 106(Suppl 2):S2-S5.
9. Han D., Wang C., Lou W., et al. Allergen-specific IL-10-secreting type I T regulatory cells, but not CD4(+)CD25(+)Foxp3(+) T cells, are decreased in peripheral blood of patients with persistent allergic rhinitis. Clin Immunol 2010, 136(2):292-301.
10. Ronmark E., Bjerg A., Perzanowski M., et al. Major increase in allergic sensitization in schoolchildren from 1996 to 2006 in northern Sweden. J Allergy Clin Immunol 2009, 124(2):357-363. e351-5.
11. Pleis J.R., Ward B.W., Lucas J.W., et al. Summary health statistics for U.S. adults: National Health Interview Survey, 2009. National Center for Health Statistics. Vital Health Stat 2010, 10(249). Available at:, Accessed April 24, 2011. http://www.cdc.gov/nchs/data/series/sr_10/sr10_249.pdf.
12. Bloom B., Cohen R.A., Freeman G., et al. Summary health statistics for U.S. children: National Health Interview Survey, 2009. National Center for Health Statistics. Vital Health Stat 2010, 10(247). Available at:, Accessed April 24, 2011. http://www.cdc.gov/nchs/data/series/sr_10/sr10_247.pdf.
13. Meltzer E.O., Bukstein D.A. The economic impact of allergic rhinitis and current guidelines for treatment. Ann Allergy Asthma Immunol 2011, 106(Suppl 2):S12-S16.
14. Ker J., Hartert T.V. The atopic march: what's the evidence?. Ann Allergy Asthma Immunol 2009, 103(4):282-289.
15. Bach J.F. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002, 347(12):911-920.
16. Okada H., Kuhn C., Feillet H., et al. The 'hygiene hypothesis' for autoimmune and allergic diseases: an update. Clin Exp Immunol 2010, 160(1):1-9.
17. Doyle W.J., Skoner D.P., Seroky J.T., et al. Reproducibility of the effects of intranasal ragweed challenges in allergic subjects. Ann Allergy Asthma Immunol 1995, 74(2):171-176.
18. Abraham C.M., Ownby D.R., Peterson E.L., et al. The relationship between seroatopy and symptoms of either allergic rhinitis or asthma. J Allergy Clin Immunol 2007, 119(5):1099-1104.
19. Bousquet J., Neukirch F., Bousquet P.J., et al. Severity and impairment of allergic rhinitis in patients consulting in primary care. J Allergy Clin Immunol 2006, 117(1):158-162.
20. Skadhauge L.R., Christensen K., Kyvik K.O., et al. Genetic and environmental influence on asthma: a population-based study of 11,688 Danish twin pairs. Eur Respir J 1999, 13(1):8-14.
21. Wallace D.V., Dykewicz M.S., Bernstein D.I., et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008, 122(Suppl 2):S1-S84.
22. Slavin R.G. Allergy is not a significant cause of nasal polyps. Arch Otolaryngol Head Neck Surg 1992, 118(3):343.
23. Franzese C.B., Burkhalter N.W. The patient with allergies. Med Clin North Am 2010, 94(5):891-902.
24. Krouse J.H., Dworkin J.P., Carron M.A., et al. Baseline laryngeal effects among individuals with dust mite allergy. Otolaryngol Head Neck Surg 2008, 139(1):149-151.
25. Arbes S.J., Gergen P.J., Elliott L., et al. Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey. J Allergy Clin Immunol 2005, 116(2):377-383.
26. Tschopp J.M., Sistek D., Schindler C., et al. Current allergic asthma and rhinitis: diagnostic efficiency of three commonly used atopic markers (IgE, skin prick tests, and Phadiatop). Results from 8329 randomized adults from the SAPALDIA Study. Swiss Study on Air Pollution and Lung Diseases in Adults. Allergy 1998, 53(6):608-613.
27. Noon L. Prophylactic inoculation against hayfever. Lancet 1911, 1:1572-1573.
28. Guidelines for the Diagnosis and Management of Food Allergy. 2010. Available at: Accessed November 14, 2010. http://www.niaid.nih.gov/topics/foodallergy/clinical/Pages/default.aspx.
29. Malm L., Gerth van Wijk R., Bachert C. Guidelines for nasal provocations with aspects on nasal patency, airflow, and airflow resistance. International Committee on Objective Assessment of the Nasal Airways, International Rhinologic Society. Rhinology 2000, 38(1):1-6.
30. Krouse J.H., Mabry R.L. Skin testing for inhalant allergy 2003: current strategies. Otolaryngol Head Neck Surg 2003, 129(Suppl 4):S33-S49.
31. Nelson H.S., Oppenheimer J., Buchmeier A., et al. An assessment of the role of intradermal skin testing in the diagnosis of clinically relevant allergy to timothy grass. J Allergy Clin Immunol 1996, 97(6):1193-1201.
32. Hamilton R.G. Clinical laboratory assessment of immediate-type hypersensitivity. J Allergy Clin Immunol 2010, 125(2 Suppl 2):S284-S296.
33. Sampson H.A. Food allergy-accurately identifying clinical reactivity. Allergy 2005, 60(Suppl 79):19-24.
34. Graif Y., Goldberg A., Tamir R., et al. Skin test results and self-reported symptom severity in allergic rhinitis: the role of psychological factors. Clin Exp Allergy 2006, 36(12):1532-1537.
35. Barbee R.A., Halonen M., Lebowitz M., et al. Distribution of IgE in a community population sample: correlations with age, sex, and allergen skin test reactivity. J Allergy Clin Immunol 1981, 68(2):106-111.
36. Day J.H., Briscoe M., Rafeiro E., et al. Comparative onset of action and symptom relief with cetirizine, loratadine, or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: confirmation of a test system. Ann Allergy Asthma Immunol 2001, 87(6):474-481.
37. Howarth P.H., Stern M.A., Roi L., et al. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis. J Allergy Clin Immunol 1999, 104(5):927-933.
38. Stubner P., Zieglmayer R., Horak F. A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit-the Vienna Challenge Chamber (VCC). Curr Med Res Opin 2004, 20(6):891-902.
39. Ratner P.H., Hampel F., Van Bavel J., et al. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2008, 100(1):74-81.
40. Pullerits T., Praks L., Ristioja V., et al. Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 2002, 109(6):949-955.
41. Grootendorst D.C., Dahlen S.E., Van Den Bos J.W., et al. Benefits of high altitude allergen avoidance in atopic adolescents with moderate to severe asthma, over and above treatment with high dose inhaled steroids. Clin Exp Allergy 2001, 31(3):400-408.
42. Frederick J.M., Warner J.O., Jessop W.J., et al. Effect of a bed covering system in children with asthma and house dust mite hypersensitivity. Eur Respir J 1997, 10(2):361-366.
43. Tovey E.R., Marks G.B., Matthews M., et al. Changes in mite allergen Der p I in house dust following spraying with a tannic acid/acaricide solution. Clin Exp Allergy 1992, 22(1):67-74.
44. Chang J.H., Becker A., Ferguson A., et al. Effect of application of benzyl benzoate on house dust mite allergen levels. Ann Allergy Asthma Immunol 1996, 77(3):187-190.
45. Munir A.K., Einarsson R., Dreborg S.K. Vacuum cleaning decreases the levels of mite allergens in house dust. Pediatr Allergy Immunol 1993, 4(3):136-143.
46. Green R., Simpson A., Custovic A., et al. The effect of air filtration on airborne dog allergen. Allergy 1999, 54(5):484-488.
47. Choi S.Y., Lee I.Y., Sohn J.H., et al. Optimal conditions for the removal of house dust mite, dog dander, and pollen allergens using mechanical laundry. Ann Allergy Asthma Immunol 2008, 100(6):583-588.
48. de Blay F., Chapman M.D., Platts-Mills T.A. Airborne cat allergen (Fel d I). Environmental control with the cat in situ. Am Rev Respir Dis 1991, 143(6):1334-1339.
49. Nageotte C., Park M., Havstad S., et al. Duration of airborne Fel d 1 reduction after cat washing. J Allergy Clin Immunol 2006, 118(2):521-522.
50. Terreehorst I., Hak E., Oosting A.J., et al. Evaluation of impermeable covers for bedding in patients with allergic rhinitis. N Engl J Med 2003, 349(3):237-246.
51. Sheikh A., Hurwitz B., Nurmatov U., et al. House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database Syst Rev 2010, 7. CD001563.
52. Gunhan K., Unlu H., Yuceturk A.V., et al. Intranasal steroids or radiofrequency turbinoplasty in persistent allergic rhinitis: effects on quality of life and objective parameters. Eur Arch Otorhinolaryngol 2011, 268(6):845-850.
53. Mori S., Fujieda S., Yamada T., et al. Long-term effect of submucous turbinectomy in patients with perennial allergic rhinitis. Laryngoscope 2002, 112(5):865-869.
54. Lin H.C., Lin P.W., Su C.Y., et al. Radiofrequency for the treatment of allergic rhinitis refractory to medical therapy. Laryngoscope 2003, 113(4):673-678.
55. Osguthorpe J.D. Immunotherapy. Curr Opin Otolaryngol Head Neck Surg 2010, 18(3):206-212.
56. Martinez-Gomez J.M., Johansen P., Erdmann I., et al. Intralymphatic injections as a new administration route for allergen-specific immunotherapy. Int Arch Allergy Immunol 2009, 150(1):59-65.
57. Calderon M.A., Alves B., Jacobson M., et al. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 2007, 1. CD001936.
58. Leatherman B.D., Owen S., Parker M., et al. Sublingual immunotherapy: past, present, paradigm for the future? A review of the literature. Otolaryngol Head Neck Surg 2007, 136(Suppl 3):S1-S20.
59. Halken S., Agertoft L., Seidenberg J., et al. Five-grass pollen 300IR SLIT tablets: efficacy and safety in children and adolescents. Pediatr Allergy Immunol 2010, 21(6):970-976.
60. Wahn U., Tabar A., Kuna P., et al. Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. J Allergy Clin Immunol 2009, 123(1):160-166. e163.
61. de Groot H., Bijl A. Anaphylactic reaction after the first dose of sublingual immunotherapy with grass pollen tablet. Allergy 2009, 64(6):963-964.